agilon health Future Growth
Future criteria checks 1/6
agilon health is forecast to grow earnings and revenue by 65% and 17.7% per annum respectively. EPS is expected to grow by 60.7% per annum. Return on equity is forecast to be -10.2% in 3 years.
Key information
65.0%
Earnings growth rate
60.7%
EPS growth rate
Healthcare earnings growth | 17.1% |
Revenue growth rate | 17.7% |
Future return on equity | -10.2% |
Analyst coverage | Good |
Last updated | 12 Jun 2024 |
Recent future growth updates
Recent updates
The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28agilon gains after boosting Medicare membership outlook
Jan 09Is There An Opportunity With agilon health, inc.'s (NYSE:AGL) 39% Undervaluation?
Dec 19agilon health: Back To Long-Term Range, Despite Underlying Market Growth
Dec 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,916 | -30 | 3 | 24 | 7 |
12/31/2025 | 7,506 | -68 | -18 | 41 | 17 |
12/31/2024 | 6,164 | -145 | -150 | -66 | 17 |
3/31/2024 | 4,866 | -202 | -185 | -143 | N/A |
12/31/2023 | 4,316 | -195 | -187 | -156 | N/A |
9/30/2023 | 3,789 | -80 | -169 | -145 | N/A |
6/30/2023 | 3,268 | -79 | -151 | -129 | N/A |
3/31/2023 | 2,789 | -83 | -200 | -168 | N/A |
12/31/2022 | 2,388 | -92 | -163 | -131 | N/A |
9/30/2022 | 2,481 | -108 | -158 | -130 | N/A |
6/30/2022 | 2,245 | -114 | -181 | -152 | N/A |
3/31/2022 | 2,074 | -391 | -145 | -131 | N/A |
12/31/2021 | 1,521 | -384 | -162 | -148 | N/A |
9/30/2021 | 1,692 | -387 | -123 | -113 | N/A |
6/30/2021 | 1,546 | -363 | -104 | -98 | N/A |
3/31/2021 | 1,340 | -69 | -74 | -68 | N/A |
12/31/2020 | 1,218 | -63 | -56 | -53 | N/A |
9/30/2020 | 1,095 | -59 | -71 | -68 | N/A |
12/31/2019 | 794 | -114 | -108 | -104 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AGL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AGL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AGL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AGL's revenue (17.7% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: AGL's revenue (17.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AGL is forecast to be unprofitable in 3 years.